Pamela Ann Connealy
CIK 1796310 · CFO & COO · last filed 2025-08-08
Pamela Ann Connealy is a CFO & COO who has filed 26 SEC Form 4 insider transactions across 4 companies since 2019. The most recent filing, for OBIO, was dated Aug 8, 2025. Across all open-market trades the lifetime net is +$229.9K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $5.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$5.67M
4
26
$229.9K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OBIO | Director | 48,711 | $4.10 | $199.7K | $0 | 8 | 2025-08-08 |
| PYXS | CFO & COO | 2,226,036 | $1.76 | $3.92M | $229.9K | 15 | 2025-04-02 |
| IMVT | Chief Financial Officer | 46,200 | $33.62 | $1.55M | $0 | 1 | 2021-03-23 |
| Immunovant, Inc. (IMVTW) Delisted | Chief Financial Officer | — | — | — | $0 | 2 | 2020-05-18 |
Recent Filings
26 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-08-08 | OBIO | Grant (A) | +15,000 | $0 | EDGAR |
| 2025-06-26 | OBIO | Grant (A) | +12,422 | $0 | EDGAR |
| 2025-04-02 | PYXS | Grant (A) | — | $0 | EDGAR |
| 2024-12-23 | PYXS | Grant (A) | — | $0 | EDGAR |
| 2024-11-27 | PYXS | Buy (P) | +88,850 | $174.4K | EDGAR |
| 2024-06-21 | OBIO | Grant (A) | +5,376 | $0 | EDGAR |
| 2024-03-28 | PYXS | Grant (A) | +328,710 | $0 | EDGAR |
| 2023-11-30 | PYXS | Tax (F) | −36,949 | -$51.7K | EDGAR |
| 2023-09-28 | PYXS | Buy (P) | +8,000 | $15.0K | EDGAR |
| 2023-09-27 | PYXS | Buy (P) | +6,426 | $11.9K | EDGAR |